Trial Identifier: | D9440C00001 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel
|
NCTID:: | NCT06122714 |
Start Date: | November 2023 |
Primary Completion Date: | October 2024 |
Study Completion Date: | October 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
US, CA | Glendale, CA, US, 91206 |
US, MD | Brooklyn, MD, US, 21225 |